Sorrento Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
18 Sep 2017	Form 4/A: Wu Yue Alexander, Director Granted 35,000 Stock Options
18 Sep 2017	Form 4/A: Deming David H, Director Granted 35,000 Stock Options
18 Sep 2017	Form 4/A: Janda Kim, Director Granted 35,000 Stock Options
18 Sep 2017	Form 4/A: Shah Jaisim, Director Granted 35,000 Stock Options
27 Apr 2017	Form 4/A: Abg Management Ltd, 10% owner and 9 others Holds 1,397,853 shares of Common Stock
10 Feb 2017	Form 4/A: Ji Henry, Director Bought 20,000 shares ($103K)
22 Nov 2013	Form 4/A: Uy George, Chief Commercial Officer Granted 47,000 Stock Options · Received 4,842 shares by conversion ($35.1K)
22 Nov 2013	Form 4/A: Uy George, Chief Commercial Officer Granted 47,000 Stock Options · Received 4,842 shares by conversion ($36.3K)
25 Feb 2010	Form 4/A: Zaniboni Steve, Director Granted 57,500 Non-qualified stock options

Comments